Transcriptomic and immunophenotypic profiling reveals molecular and immunological hallmarks of colorectal cancer tumourigenesis
Open Access
Abstract
Objective: Biological insights into the stepwise development and progression of colorectal cancer (CRC) are imperative to develop tailored approaches for early detection and optimal clinical management of this disease. Here, we aimed to dissect the transcriptional and immunologic alterations that accompany malignant transformation in CRC and to identify clinically relevant biomarkers through spatial profiling of pT1 CRC samples.Design: We employed digital spatial profiling (GeoMx) on eight pT1 CRCs to study gene expression in the epithelial and stromal segments across regions of distinct histology, including normal mucosa, low-grade and high-grade dysplasia and cancer. Consecutive histology sections were profiled by imaging mass cytometry to reveal immune contextures. Finally, publicly available single-cell RNA-sequencing data was analysed to determine the cellular origin of relevant transcripts.Results: Comparison of gene expression between regions within pT1 CRC samples identified differentially expressed genes in the epithelium (n=1394 genes) and the stromal segments (n=1145 genes) across distinct histologies. Pathway analysis identified an early onset of inflammatory responses during malignant transformation, typified by upregulation of gene signatures such as innate immune sensing. We detected increased infiltration of myeloid cells and a shift in macrophage populations from pro-inflammatory HLA-DR+CD204−macrophages to HLA-DR−CD204+immune-suppressive subsets from normal tissue through dysplasia to cancer, accompanied by the upregulation of the CD47/SIRPα ‘don’t eat me signal’.Conclusion: Spatial profiling revealed the molecular and immunological landscape of CRC tumourigenesis at early disease stage. We identified biomarkers with strong association with disease progression as well as targetable immune processes that are exploitable in a clinical setting.Keywords
Funding Information
- H2020 European Research Council (852832)
- European Cooperation in Science and Technology (CA17118)
- Stichting Management Apothekers en de Gezondheidszorg (STIMAG) 2021 (STIMAG2021)
This publication has 61 references indexed in Scilit:
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?Science, 2013
- Pro-Neoplastic Effects of Amphiregulin in Colorectal CarcinogenesisJournal of Gastrointestinal Cancer, 2012
- Molecular pathways undergoing dramatic transcriptomic changes during tumor development in the human colonBMC Cancer, 2012
- Cancer Cell Metabolism: One Hallmark, Many FacesCancer Discovery, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- The essential role of the in situ immune reaction in human colorectal cancerJournal of Leukocyte Biology, 2008
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- On Respiratory Impairment in Cancer CellsScience, 1956